[Correction of CFTR anomalies: pharmacological approach].
Chinet
T
T
Laboratoire de biologie et pharmacologie des épithéliums respiratoires, université Paris-V, hôpital Ambroise Paré, Boulogne, France.
D002648:Child; D018118:Chloride Channels / Q000187:drug effects / Q000235:genetics; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000188:drug therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000187:drug effects / Q000235:genetics*; D004252:DNA Mutational Analysis; D006801:Humans; D011379:Prognosis; D015222:Sodium Channels / Q000187:drug effects / Q000235:genetics
C505032:CFTR protein, human; D018118:Chloride Channels; D015222:Sodium Channels; D019005:Cystic Fibrosis Transmembrane Conductance Regulator